Volume 13, Number 1—January 2007
Research
Blood Transfusion and Spread of Variant Creutzfeldt-Jakob Disease
Figure 2

Figure 2. Absolute prevalence of infection for an incubation period of 16 (A) and 50 (B) years, for nonrecipients of blood transfusion (solid, black), recipients under the assumption of no infectivity (dashed, grey), of 100% infectivity without donor exclusion (dotted, black), and 100% infectivity with donor exclusion (solid, gray). The prevalence declines after the alimentary route of transmission is interrupted, i.e., after 10 years. Prevalence differs only slightly if the infection probability of a transfusion from an infected donor is increased from 0% to 100%. Donor exclusion produces negligible reductions.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.